CIK 0001757073 · Large accelerated filer
Envista Holdings Corp
Sign in to watch- Ticker
- NVST
- Exchange
- NYSE
- Industry
- Dental Equipment & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832206728
- Phone
- 714-817-5418
- Business address
- 200 S. KRAEMER BLVD., BLDG. E, BREA, CA, 92821
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $220,000
- in 1 filing, $220K under 10b5-1 plans
Net −$220,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-25 | Nance Mark E General Counsel | Grant or award · Performance Share Unit | +33,455 | 33,455 | ||
| 2025-02-25 | Nance Mark E General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +42,370 | 42,370 | ||
| 2025-02-01 | Befidi Robert President, Diagnostics | Grant or award · Envista deferred contribution programs - Envista Stock Fund | +1,151 | $20.52 | $24K | 1,151 |
| 2025-02-01 | Nance Mark E General Counsel | Grant or award · Envista deferred contribution programs - Envista Stock Fund | +965 | $20.52 | $20K | 5,581 |
| 2025-02-01 | Kaabi Faez C Chief Accounting Officer | Grant or award · Envista deferred contribution programs - Envista Stock Fund | +689 | $20.52 | $14K | 3,854 |
| 2025-02-01 | Reis Mischa SVP, Strategy & Bus. Dev. | Grant or award · Executive Deferred Incentive Program - Envista Stock Fund | +3,152 | $20.52 | $65K | 26,438 |
| 2024-11-01 | Keel Paul A Chief Executive Officer | Shares withheld for taxes | −53,996 | $20.94 | $1.1M | 348,609 |
| 2024-09-17 | Reis Mischa SVP, Strategy & Bus. Dev. | Shares withheld for taxes | −812 | $19.00 | $15K | 42,720 |
| 2024-08-25 | Nance Mark E General Counsel | Grant or award · Performance Option | +95,240 | 95,240 | ||
| 2024-08-25 | Keel Paul A Chief Executive Officer | Grant or award · Performance Option | +485,680 | 485,680 | ||
| 2024-08-25 | Reis Mischa SVP, Strategy & Bus. Dev. | Grant or award · Performance Option | +57,980 | 57,980 | ||
| 2024-08-25 | Befidi Robert President, Diagnostics | Shares withheld for taxes | −3,454 | $18.70 | $65K | 39,791 |
| 2024-08-25 | Befidi Robert President, Diagnostics | Grant or award · Performance Option | +70,400 | 70,400 | ||
| 2024-08-25 | Hammes Eric D. Chief Financial Officer | Grant or award | +64,175 | 88,707 | ||
| 2024-08-13 | Keel Paul A Chief Executive Officer | Purchase | +30,000 | $16.87 | $506K | 402,605 |
| 2024-08-12 | Hammes Eric D. Chief Financial Officer | Purchase | +24,532 | $16.33 | $401K | 24,532 |
| 2024-07-15 | Nance Mark E General Counsel | Shares withheld for taxes | −491 | $15.94 | $8K | 57,481 |
| 2024-06-25 | Keller Stephen Principal Financial Officer | Grant or award | +31,250 | 53,803 | ||
| 2024-05-25 | Conley Eric SVP, Orthodontics | Shares withheld for taxes | −642 | $18.25 | $12K | 53,223 |
| 2024-05-25 | Keel Paul A Chief Executive Officer | Grant or award | +71,235 | 71,235 |
Page 6 of 9 · 175 trades